(Q53338455)

English

Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages.

scientific article published in March 2000

Statements

Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit